[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market - Global Outlook and Forecast 2021-2027

April 2021 | 107 pages | ID: DF40FE20B462EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology in Global, including the following market information:

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Segment Percentages, By Type, 2020 (%)
  • Chemotherapeutic Agent
  • Radiation Therapy
  • Drug-eluting Particles
China Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Specialty Clinics
Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Abbott Laboratories (Abbott EP)
  • ABK Biomedical, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • Cook Medical, Inc.
  • Medtronic, Inc.
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • TriSalus Life Sciences
  • Terumo Corporation
  • Vascular Solutions, Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRUG ELUTING BEADS, MICROCATHETERS AND RADIOPAQUE BEADS IN INTERVENTIONAL ONCOLOGY OVERALL MARKET SIZE

2.1 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size: 2021 VS 2027
2.2 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players in Global Market
3.2 Top Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies Ranked by Revenue
3.3 Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue by Companies
3.4 Top 3 and Top 5 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players in Global Market
  3.6.1 List of Global Tier 1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size Markets, 2021 & 2027
  4.1.2 Chemotherapeutic Agent
  4.1.3 Radiation Therapy
  4.1.4 Drug-eluting Particles
4.2 By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue & Forecasts
  4.2.1 By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2021
  4.2.2 By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2022-2027
  4.2.3 By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
5.2 By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue & Forecasts
  5.2.1 By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2021
  5.2.2 By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2022-2027
  5.2.3 By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2021 & 2027
6.2 By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue & Forecasts
  6.2.1 By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2021
  6.2.2 By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2022-2027
  6.2.3 By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027
  6.3.2 US Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.3.3 Canada Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.3.4 Mexico Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027
  6.4.2 Germany Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.3 France Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.4 U.K. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.5 Italy Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.6 Russia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.7 Nordic Countries Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.4.8 Benelux Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027
  6.5.2 China Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.5.3 Japan Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.5.4 South Korea Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.5.5 Southeast Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.5.6 India Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027
  6.6.2 Brazil Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.6.3 Argentina Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027
  6.7.2 Turkey Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.7.3 Israel Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.7.4 Saudi Arabia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027
  6.7.5 UAE Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Abbott Laboratories (Abbott EP)
  7.1.1 Abbott Laboratories (Abbott EP) Corporate Summary
  7.1.2 Abbott Laboratories (Abbott EP) Business Overview
  7.1.3 Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.1.4 Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.1.5 Abbott Laboratories (Abbott EP) Key News
7.2 ABK Biomedical, Inc.
  7.2.1 ABK Biomedical, Inc. Corporate Summary
  7.2.2 ABK Biomedical, Inc. Business Overview
  7.2.3 ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.2.4 ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.2.5 ABK Biomedical, Inc. Key News
7.3 Boston Scientific Corporation
  7.3.1 Boston Scientific Corporation Corporate Summary
  7.3.2 Boston Scientific Corporation Business Overview
  7.3.3 Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.3.4 Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.3.5 Boston Scientific Corporation Key News
7.4 BTG plc
  7.4.1 BTG plc Corporate Summary
  7.4.2 BTG plc Business Overview
  7.4.3 BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.4.4 BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.4.5 BTG plc Key News
7.5 Cook Medical, Inc.
  7.5.1 Cook Medical, Inc. Corporate Summary
  7.5.2 Cook Medical, Inc. Business Overview
  7.5.3 Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.5.4 Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.5.5 Cook Medical, Inc. Key News
7.6 Medtronic, Inc.
  7.6.1 Medtronic, Inc. Corporate Summary
  7.6.2 Medtronic, Inc. Business Overview
  7.6.3 Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.6.4 Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.6.5 Medtronic, Inc. Key News
7.7 Merit Medical Systems, Inc.
  7.7.1 Merit Medical Systems, Inc. Corporate Summary
  7.7.2 Merit Medical Systems, Inc. Business Overview
  7.7.3 Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.4.4 Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.7.5 Merit Medical Systems, Inc. Key News
7.8 Stryker Corporation
  7.8.1 Stryker Corporation Corporate Summary
  7.8.2 Stryker Corporation Business Overview
  7.8.3 Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.8.4 Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.8.5 Stryker Corporation Key News
7.9 TriSalus Life Sciences
  7.9.1 TriSalus Life Sciences Corporate Summary
  7.9.2 TriSalus Life Sciences Business Overview
  7.9.3 TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.9.4 TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.9.5 TriSalus Life Sciences Key News
7.10 Terumo Corporation
  7.10.1 Terumo Corporation Corporate Summary
  7.10.2 Terumo Corporation Business Overview
  7.10.3 Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.10.4 Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.10.5 Terumo Corporation Key News
7.11 Vascular Solutions, Inc.
  7.11.1 Vascular Solutions, Inc. Corporate Summary
  7.11.2 Vascular Solutions, Inc. Business Overview
  7.11.3 Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Major Product Offerings
  7.11.4 Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (2016-2021)
  7.11.5 Vascular Solutions, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Opportunities & Trends in Global Market
Table 2. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Drivers in Global Market
Table 3. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Restraints in Global Market
Table 4. Key Players of Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology in Global Market
Table 5. Top Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Type
Table 9. List of Global Tier 1 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories (Abbott EP) Corporate Summary
Table 31. Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 32. Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 33. ABK Biomedical, Inc. Corporate Summary
Table 34. ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 35. ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 36. Boston Scientific Corporation Corporate Summary
Table 37. Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 38. Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 39. BTG plc Corporate Summary
Table 40. BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 41. BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 42. Cook Medical, Inc. Corporate Summary
Table 43. Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 44. Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 45. Medtronic, Inc. Corporate Summary
Table 46. Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 47. Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 48. Merit Medical Systems, Inc. Corporate Summary
Table 49. Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 50. Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 51. Stryker Corporation Corporate Summary
Table 52. Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 53. Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 54. TriSalus Life Sciences Corporate Summary
Table 55. TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 56. TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 57. Terumo Corporation Corporate Summary
Table 58. Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 59. Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 60. Vascular Solutions, Inc. Corporate Summary
Table 61. Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Product Offerings
Table 62. Vascular Solutions, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Segment by Type
Figure 2. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Segment by Application
Figure 3. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue in 2020
Figure 8. By Type - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 9. By Application - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 10. By Region - Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 11. By Country - North America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 12. US Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 16. Germany Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 17. France Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 24. China Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 28. India Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 30. Brazil Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Market Share, 2016-2027
Figure 33. Turkey Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories (Abbott EP) Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. ABK Biomedical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Boston Scientific Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BTG plc Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Cook Medical, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Medtronic, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merit Medical Systems, Inc. Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Stryker Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. TriSalus Life Sciences Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Terumo Corporation Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications